Bioequivalence Study of 2 Sizes of SHR4640 Tablets Orally in Healthy Subjects
Status:
Completed
Trial end date:
2024-01-13
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the pharmacokinetic, and safety of two sizes of
SHR4640 tablets in healthy adults, to explore the bioequivalence between two sizes of SHR4640
tablets.